Is anyone else on the avonex + methotrexate combination?
I had been on avonex + cellcept but the cellcept side effects
were not worth it (finally figured out that was what was
causing the diarrhea). So the (new) doc has switched me
to methotrexate instead. The little research I did showed it
to be "mildly" better than avonex alone.
Does anyone have better info on methotrexate and its use
in MS?
avonex + methotrexate
Re: avonex + methotrexate
I don't take this medication, but there seems to be abundant information available on it through the web.batpere wrote:Does anyone have better info on methotrexate and its use in MS?
Here's some information from the Mayo Clinic on Methotrexate. It isn't specific for it's use in MS but it does provide a good deal of information on the medication.
In addition, here's a brief statement about methortrexate from the UCSF MS Center.
From the National MS Society:Methotrexate Methotrexate (Rheumatrex) is relatively mild immunosuppressant in widespread use for other inflammatory neurological conditions such as myasthenia gravis or demyelinating peripheral neuropathies. In MS, it has been reported to slow the progression of upper extremity dysfunction in patients with SPMS, although a comparable benefit on the progression of lower extremity dysfunction was not demonstrated in this study. It is generally well tolerated by patients at single weekly doses ranging from 7.5 to 20 mg orally. Some patients experience nausea, headache, or diarrhea but these side effects rarely necessitate discontinuation of treatment, particularly at the lower doses used for treating MS. Complete Blood Counts (CBCs), in addition to tests of hepatic and renal function, should be followed in all patients. Some patients will develop irreversible liver damage following prolonged treatment (>2 years) and many experts recommend a blind liver biopsy in that setting so that drug-related hepatic toxicity can be detected early. There also may be an increased long-term risk of developing non-Hodgkin’s lymphoma following therapy.
NHEMethotrexate
Methotrexate is a synthetic immunosuppressive drug that is highly effective in the short-term against rheumatoid arthritis, an autoimmune disease. It also effectively prevents EAE, the animal model for MS.
Although a clinical trial of methotrexate in the 1970s did not show benefit to MS patients, there has been renewed interest in the drug and a recent controlled trial showed the drug had modest benefit. In this trial, 30 people with primary or secondary progressive MS who were still able to walk received weekly low-dose methotrexate. Deterioration of arm function was slowed, compared to the arm function of those receiving a placebo, but there was no difference in worsening of leg function, or in overall disability.
Re: avonex + methotrexate
NHE wrote: In addition, here's a brief statement about methortrexate from the UCSF MS Center.
From the National MS Society:Methotrexate Methotrexate (Rheumatrex) is relatively mild immunosuppressant in widespread use for other inflammatory neurological conditions such as myasthenia gravis or demyelinating peripheral neuropathies. In MS, it has been reported to slow the progression of upper extremity dysfunction in patients with SPMS, although a comparable benefit on the progression of lower extremity dysfunction was not demonstrated in this study. It is generally well tolerated by patients at single weekly doses ranging from 7.5 to 20 mg orally. Some patients experience nausea, headache, or diarrhea but these side effects rarely necessitate discontinuation of treatment, particularly at the lower doses used for treating MS. Complete Blood Counts (CBCs), in addition to tests of hepatic and renal function, should be followed in all patients. Some patients will develop irreversible liver damage following prolonged treatment (>2 years) and many experts recommend a blind liver biopsy in that setting so that drug-related hepatic toxicity can be detected early. There also may be an increased long-term risk of developing non-Hodgkin’s lymphoma following therapy.
NHEMethotrexate
Methotrexate is a synthetic immunosuppressive drug that is highly effective in the short-term against rheumatoid arthritis, an autoimmune disease. It also effectively prevents EAE, the animal model for MS.
Although a clinical trial of methotrexate in the 1970s did not show benefit to MS patients, there has been renewed interest in the drug and a recent controlled trial showed the drug had modest benefit. In this trial, 30 people with primary or secondary progressive MS who were still able to walk received weekly low-dose methotrexate. Deterioration of arm function was slowed, compared to the arm function of those receiving a placebo, but there was no difference in worsening of leg function, or in overall disability.
Thanks. Seems that it has the same lymphoma warning that CellCept also had. It was the latter NMSS modest benefit statement that I had read that didn't make methotrexate sound like it was going to be much help. He did prescribe the 7.5 mg weekly dose. Good to know about the 2-year limit too. I'll stick that in my electronic calendar to remind me, because I know I will have soon forgotten that fact.
I'll have to research it more when I'm feeling better. Got a cold this week and am somewhat bummed after my first visit with the new neuro. I really liked the old one but she moved away and I had to find another one. I came away optimistic from each session before, but not this time.
thanks again for the links.